The Clinical and Scientific Team at MISSION Therapeutics is responsible for driving the development and clinical validation of small molecule drugs targeting deubiquitylating enzymes (DUBs). The team combines expertise in medical strategy, scientific research, clinical trial management, and bioinformatics to advance therapeutic candidates from discovery through regulatory approval.
View all